- September-October 2018, Volume 15, Issue 5
In this issue, Dr. Julie Kanter interviews David Issom, who shares his journey from patient living with SCD to scientist and advocate; Dr. Sujit Sheth discusses advances in therapies used to treat β thalassemia syndromes; and Dr. Roy Silverstein talks about his meeting with U.S. HHS leadership.
- July-August 2018, Volume 15, Issue 4
In this issue, Dr. Kendra Sweet discusses TKI cessation as a treatment option for chronic phase CML; Dr. Jenny Despotovic provides coverage of emerging therapies in immune thrombocytopenia; and Drs. LeBlanc and Litzow discuss whether transfusions are a barrier to high-quality end-of-life care in hematology.
- May-June 2018, Volume 15, Issue 3
In this issue, Dr. Michaelis discusses her "Off the Shelf" pick; Dr. Jay Menitove covers recent and current pressures placed on the U.S. blood system; Drs. Balitsky and Arnold argue for new studies of anticoagulation in thrombocytopenia; and Dr. Moss covers the CLARITY trial.
- March-April 2018, Volume 15, Issue 2
In this issue, Drs. Molly Mandernach and Annie Im share the participant's view of the ASH Medical Educators Institute; Drs. Ljungman and Lazarus discuss CMV infection prevention in AHCT patients; Dr. Michael B. Jordan reviews breakthrough therapies for HLH disorder; and the co-chairs of the ASH Summit on Emerging Immunotherapies for Hematologic Diseases share thoughts on what to anticipate at the July meeting.
- January-February 2018, Volume 15, Issue 1
In this issue, ASH President Dr. Alexis Thompson ushers in 2018 with annual meeting media highlights; Dr. Baumann Kreuziger discusses antithrombotic therapy in adults undergoing LVAD placement; Contributing Editors cover the top 12 most influential breakthroughs of 2017; and Dr. Saad Usmani continues his coverage of the highlights in Atlanta at this year's annual meeting.